Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
CytoDyn Inc. (CYDY) had Return on Tangible Equity of 38.92% for the most recently reported fiscal year, ending 2026-05-31.
| Income Statement Financials | |
-- |
|
$-42.70M |
|
-- |
|
-- |
|
$38.58M |
|
$-38.58M |
|
$-4.12M |
|
$-42.70M |
|
$-42.70M |
|
$-42.70M |
|
$-42.70M |
|
$-42.70M |
|
$-42.70M |
|
$-38.58M |
|
$-38.56M |
|
1.29B |
|
1.29B |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$13.88M |
|
-- |
|
$0.10M |
|
$13.97M |
|
$53.73M |
|
$26.34M |
|
$69.96M |
|
$123.69M |
|
$-109.72M |
|
$-109.72M |
|
$-109.72M |
|
1.37B |
|
| Cash Flow Statement Financials | |
$-17.25M |
|
-- |
|
$17.20M |
|
$11.90M |
|
$11.85M |
|
$-0.05M |
|
$1.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.26 |
|
-- |
|
-- |
|
-0.32 |
|
-0.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-17.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
38.92% |
|
|
Return on Tangible Equity |
38.92% |
-305.58% |
|
51.21% |
|
$-0.08 |
|
$-0.01 |
|
$-0.01 |
|